Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Revenue (2016 - 2026)

Apyx Medical filings provide 15 years of Revenue readings, the most recent being $19.2 million for Q4 2025.

  • On a quarterly basis, Revenue rose 34.75% to $19.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $52.8 million, a 9.86% increase, with the full-year FY2025 number at $52.8 million, up 9.86% from a year prior.
  • Revenue hit $19.2 million in Q4 2025 for Apyx Medical, up from $12.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $19.2 million in Q4 2025 to a low of $8.6 million in Q1 2021.
  • Median Revenue over the past 5 years was $12.1 million (2023), compared with a mean of $12.3 million.
  • Biggest five-year swings in Revenue: skyrocketed 161.27% in 2021 and later dropped 25.04% in 2022.
  • Apyx Medical's Revenue stood at $16.8 million in 2021, then fell by 25.04% to $12.6 million in 2022, then grew by 16.26% to $14.7 million in 2023, then dropped by 3.0% to $14.2 million in 2024, then surged by 34.75% to $19.2 million in 2025.
  • The last three reported values for Revenue were $19.2 million (Q4 2025), $12.9 million (Q3 2025), and $11.4 million (Q2 2025) per Business Quant data.